All three mentioned options have been documented in CRC and all of them are interrelated via common signaling pathways as well as shared signals and regulators including BECN1, BCL-2, mTOR, AMP-activated protein kinase (AMPK), and select microRNAs [123,124,125,126]. The gene discussed is BCL2; the disease is colorectal carcinoma.